title: Thirty Years After the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trial: A New Era for Stroke Therapy.
authors.affiliation: Departments of Neurology, Anesthesiology, and Surgery, University of Massachusetts Medical School, Worcester2Departments of Neurology, Anesthesiology, and Surgery, UMass Memorial Medical Center, Worcester, Massachusetts.
authors.forename: Raphael A
authors.initials: RA
authors.lastname: Carandang
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D055825:National Institute of Neurological Disorders and Stroke (U.S.); D011994:Recombinant Proteins; D020521:Stroke / Q000188:drug therapy; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator